250 related articles for article (PubMed ID: 1966779)
1. Beta-lipotropin/adrenocorticotropic hormone responses to corticotropin releasing hormone, hypoglycemia, metyrapone and dexamethasone in normal human subjects.
Castro M; Moreira AC
Braz J Med Biol Res; 1990; 23(11):1107-15. PubMed ID: 1966779
[TBL] [Abstract][Full Text] [Related]
2. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
[TBL] [Abstract][Full Text] [Related]
3. Pulsatile human corticotropin-releasing hormone prevents dexamethasone-induced suppression of the plasma cortisol response to hypoglycemia in normal men.
Avgerinos PC; Kiamouris CK; Petrakos IP; Kleanthous IK; Zorzos PA; Dimitriadis TN; Raptis SA; Cutler GB
J Clin Endocrinol Metab; 1992 Nov; 75(5):1358-61. PubMed ID: 1331166
[TBL] [Abstract][Full Text] [Related]
4. Synthetic ovine corticotropin-releasing hormone: simultaneous release of proopiolipomelanocortin peptides in man.
Jackson RV; DeCherney GS; DeBold CR; Sheldon WR; Alexander AN; Rivier J; Vale W; Orth DN
J Clin Endocrinol Metab; 1984 Apr; 58(4):740-3. PubMed ID: 6321535
[TBL] [Abstract][Full Text] [Related]
5. Evidence against changes in corticotroph CRF receptors in depressed patients.
Young EA; Akil H; Haskett RF; Watson SJ
Biol Psychiatry; 1995 Mar; 37(6):355-63. PubMed ID: 7772643
[TBL] [Abstract][Full Text] [Related]
6. Effects of low dose ovine corticotropin-releasing hormone in humans: endocrine relationships and beta-endorphin/beta-lipotropin responses.
Watson SJ; Lopez JF; Young EA; Vale W; Rivier J; Akil H
J Clin Endocrinol Metab; 1988 Jan; 66(1):10-5. PubMed ID: 2826522
[TBL] [Abstract][Full Text] [Related]
7. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
[TBL] [Abstract][Full Text] [Related]
8. Plasma immunoreactive joining peptide in man: a new marker of proopiomelanocortin processing and corticotroph function.
Phlipponneau M; Lenne F; Proeschel MF; Girard F; Luton JP; Bertagna X
J Clin Endocrinol Metab; 1993 Feb; 76(2):325-9. PubMed ID: 8381797
[TBL] [Abstract][Full Text] [Related]
9. Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man.
Ur E; Capstick C; McLoughlin L; Checkley S; Besser GM; Grossman A
Neuroendocrinology; 1995 Feb; 61(2):191-7. PubMed ID: 7753338
[TBL] [Abstract][Full Text] [Related]
10. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[TBL] [Abstract][Full Text] [Related]
11. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
[TBL] [Abstract][Full Text] [Related]
12. Plasma pro-opiomelanocortin fragments and adrenal steroids following administration of metyrapone to normal and hirsute women.
Cunningham SK; Loughlin T; Bertagna X; Girard F; McKenna TJ
J Endocrinol Invest; 1988 Apr; 11(4):247-53. PubMed ID: 2842388
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
Chan JS; Lu CL; Seidah NG; Chretien M
Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
[TBL] [Abstract][Full Text] [Related]
14. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
Watanobe H; Tamura T
J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
[TBL] [Abstract][Full Text] [Related]
15. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.
Motomatsu T; Takahashi H; Ibayashi H; Nobunaga M
J Clin Endocrinol Metab; 1984 Sep; 59(3):495-8. PubMed ID: 6086700
[TBL] [Abstract][Full Text] [Related]
16. The hormonal actions of corticotropin-releasing factor in sheep: effect of intravenous and intracerebroventricular injection.
Donald RA; Redekopp C; Cameron V; Nicholls MG; Bolton J; Livesey J; Espiner EA; Rivier J; Vale W
Endocrinology; 1983 Sep; 113(3):866-70. PubMed ID: 6307669
[TBL] [Abstract][Full Text] [Related]
17. Adrenocorticotropic hormone, beta-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone.
Maes M; Meltzer H; Cosyns P; Calabrese J; D'Hondt P; Blockx P
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1273-92. PubMed ID: 7863016
[TBL] [Abstract][Full Text] [Related]
18. The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglycemia.
Goji K
Acta Endocrinol (Copenh); 1989 Mar; 120(3):390-4. PubMed ID: 2538990
[TBL] [Abstract][Full Text] [Related]
19. Diurnal rhythms of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in normal subjects and in patients with Addison's disease and Cushing's disease.
Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H
Endocrinol Jpn; 1986 Oct; 33(5):713-9. PubMed ID: 3030713
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of human plasma immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin using immuno-affinity chromatography.
Yamaguchi H; Liotta AS; Krieger DT
J Clin Endocrinol Metab; 1980 Nov; 51(5):1002-8. PubMed ID: 6252227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
